Replies to post #6545 on GTC Biotherapeutics (fka GTCB)

[jessellivermore]

Dear biopearl....

Consider yourself on the list. :)Yes I have met Judah and actually sat next to him at a meeting he spoke at on his then new idea of angiogenesis factor. He came on the idea he said because he had always wondered why women with breast cancer could be diagnosed treated and go into remission for long periods; and suddenly the tumor would recur and spread rapidly through their body. This lead him to the conclusion eventually that the tumors needed AG factor to become active. He was a legend at HMS and replaced Dr.Gross as chief of Surgery at CHMC even though he never did any surgery.

I do not know about Entremed. I know he had some relationship with Geron.

[mabgoat]

Biopearl

I also bought those stocks and thought they were great. Sold off though before they got reabsorbed back into Gensyme, or whatever else happened.

The worst Mab so far for cost is Soliris (Eculizumab) For Paroxysmal Nocturnal Hemoglobimuria.

The treatment consists of 4 weekly treatments, then an every other week treatment for next 5 months.

The total cost for this Mab is $360,000. This is for 6 months of treatment. And this does not permanently control the disease, just decreases transfusion requirements.

We do have a patient with PNH, who is fully insured. The patients deductible is $60,000. So far no treatment has been done.

I am here for the technology, more so than Atryn, especially for the Mab's.

When you put plasma proteins together with Mab's this company should be a powerhouse.